Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma

This cohort study examines the risk of skeletal-related events associated with the frequency of bisphosphonate treatment in patients with multiple myeloma.

Detalles Bibliográficos
Autores principales: Zhou, Jifang, Sweiss, Karen, Han, Jin, Ko, Naomi Y., Patel, Pritesh R., Chiu, Brian C.-H., Calip, Gregory S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316999/
https://www.ncbi.nlm.nih.gov/pubmed/34313746
http://dx.doi.org/10.1001/jamanetworkopen.2021.18410
_version_ 1783729983963791360
author Zhou, Jifang
Sweiss, Karen
Han, Jin
Ko, Naomi Y.
Patel, Pritesh R.
Chiu, Brian C.-H.
Calip, Gregory S.
author_facet Zhou, Jifang
Sweiss, Karen
Han, Jin
Ko, Naomi Y.
Patel, Pritesh R.
Chiu, Brian C.-H.
Calip, Gregory S.
author_sort Zhou, Jifang
collection PubMed
description This cohort study examines the risk of skeletal-related events associated with the frequency of bisphosphonate treatment in patients with multiple myeloma.
format Online
Article
Text
id pubmed-8316999
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-83169992021-08-13 Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma Zhou, Jifang Sweiss, Karen Han, Jin Ko, Naomi Y. Patel, Pritesh R. Chiu, Brian C.-H. Calip, Gregory S. JAMA Netw Open Research Letter This cohort study examines the risk of skeletal-related events associated with the frequency of bisphosphonate treatment in patients with multiple myeloma. American Medical Association 2021-07-27 /pmc/articles/PMC8316999/ /pubmed/34313746 http://dx.doi.org/10.1001/jamanetworkopen.2021.18410 Text en Copyright 2021 Zhou J et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Zhou, Jifang
Sweiss, Karen
Han, Jin
Ko, Naomi Y.
Patel, Pritesh R.
Chiu, Brian C.-H.
Calip, Gregory S.
Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
title Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
title_full Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
title_fullStr Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
title_full_unstemmed Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
title_short Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
title_sort evaluation of frequency of administration of intravenous bisphosphonate and recurrent skeletal-related events in patients with multiple myeloma
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316999/
https://www.ncbi.nlm.nih.gov/pubmed/34313746
http://dx.doi.org/10.1001/jamanetworkopen.2021.18410
work_keys_str_mv AT zhoujifang evaluationoffrequencyofadministrationofintravenousbisphosphonateandrecurrentskeletalrelatedeventsinpatientswithmultiplemyeloma
AT sweisskaren evaluationoffrequencyofadministrationofintravenousbisphosphonateandrecurrentskeletalrelatedeventsinpatientswithmultiplemyeloma
AT hanjin evaluationoffrequencyofadministrationofintravenousbisphosphonateandrecurrentskeletalrelatedeventsinpatientswithmultiplemyeloma
AT konaomiy evaluationoffrequencyofadministrationofintravenousbisphosphonateandrecurrentskeletalrelatedeventsinpatientswithmultiplemyeloma
AT patelpriteshr evaluationoffrequencyofadministrationofintravenousbisphosphonateandrecurrentskeletalrelatedeventsinpatientswithmultiplemyeloma
AT chiubrianch evaluationoffrequencyofadministrationofintravenousbisphosphonateandrecurrentskeletalrelatedeventsinpatientswithmultiplemyeloma
AT calipgregorys evaluationoffrequencyofadministrationofintravenousbisphosphonateandrecurrentskeletalrelatedeventsinpatientswithmultiplemyeloma

Ejemplares similares